✦ LIBER ✦

Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib

✍ Scribed by Paul La Rosée, Philippe Martiat, Armin Leitner, Thomas Klag…

Book ID: 120775827
Publisher: Springer
Year: 2013
Tongue: English
Weight: 151 KB
Volume: 92
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-013-1769-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dasatinib: From Treatment of Imatinib-Re

Dasatinib: From Treatment of Imatinib-Resistant or -Intolerant Patients With Chronic Myeloid Leukemia to Treatment of Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

✍ Brian L. Abbott 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Treatment options for patients with chro

Treatment options for patients with chronic myeloid leukemia who are resistant to or unable to tolerate imatinib

✍ Brady Stein; B. Douglas Smith 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 898 KB

Dasatinib induces significant hematologi

Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase

✍ Guilhot, F.; Apperley, J.; Kim, D.-W.; Bullorsky, E. O.; Baccarani, M.; Roboz, G 📂 Article 📅 2007 🏛 American Society of Hematology 🌐 English ⚖ 137 KB

Dasatinib induces complete hematologic a

Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis

✍ Cortes, J.; Rousselot, P.; Kim, D.-W.; Ritchie, E.; Hamerschlak, N.; Coutre, S.; 📂 Article 📅 2006 🏛 American Society of Hematology 🌐 English ⚖ 118 KB

Lack of non-hematological cross intolera

Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia: a retrospective safety analysis

✍ Yukio Kobayashi; Hisashi Sakamaki; Shin Fujisawa; Kiyoshi Ando; Kazuhito Yamamot 📂 Article 📅 2011 🏛 Carden Jennings Publishing 🌐 English ⚖ 152 KB

A retrospective analysis of therapy adhe

A retrospective analysis of therapy adherence in imatinib resistant or intolerant patients with chronic myeloid leukemia receiving nilotinib or dasatinib in a real-world setting

✍ Guérin, Annie; Chen, Lei; Wu, Eric Q.; Ponce de Leon, Diego; Griffin, James D. 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 174 KB